Alain Schreiber, Director, 10% Owner at CADENCE PHARMACEUTICALS INC (CADX), sold 36,900 shares at $14.37 ($519K) on 2007-09-19, disclosed to the SEC on 2007-09-19.
Open-market sale of $519k CADX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.50 | 200 | $3K | 0.5% |
| 2 | $13.50 | 7,900 | $107K | 20.5% |
| 3 | $14.10 | 10,286 | $145K | 27.9% |
| 4 | $14.11 | 2,027 | $29K | 5.5% |
| 5 | $14.12 | 100 | $1K | 0.3% |
| 6 | $14.13 | 600 |
| $8K |
| 1.6% |
| 7 | $14.15 | 1,757 | $25K | 4.8% |
| 8 | $14.16 | 200 | $3K | 0.5% |
| 9 | $14.17 | 1,300 | $18K | 3.5% |
| 10 | $14.18 | 400 | $6K | 1.1% |
| 11 | $14.19 | 200 | $3K | 0.5% |
| 12 | $14.20 | 630 | $9K | 1.7% |
| 13 | $14.24 | 100 | $1K | 0.3% |
| 14 | $14.26 | 100 | $1K | 0.3% |
| 15 | $14.27 | 915 | $13K | 2.5% |
| 16 | $14.31 | 900 | $13K | 2.5% |
| 17 | $14.35 | 300 | $4K | 0.8% |
| 18 | $14.37 | 100 | $1K | 0.3% |
| 19 | $14.38 | 200 | $3K | 0.6% |
| 20 | $14.40 | 5,685 | $82K | 15.8% |
| 21 | $14.41 | 400 | $6K | 1.1% |
| 22 | $14.44 | 400 | $6K | 1.1% |
| 23 | $14.45 | 100 | $1K | 0.3% |
| 24 | $14.51 | 100 | $1K | 0.3% |
| 25 | $14.53 | 100 | $1K | 0.3% |
| 26 | $14.54 | 300 | $4K | 0.8% |
| 27 | $14.55 | 300 | $4K | 0.8% |
| 28 | $14.56 | 400 | $6K | 1.1% |
| 29 | $14.57 | 700 | $10K | 2.0% |
| 30 | $14.59 | 200 | $3K | 0.6% |
| Total | $14.07 avg | 36,900 | $519K | 100% |
| Filing → |
| IMDZ | SELL | 2015-04-16 | $1.5M | — | Filing → |
| IMDZ | SELL | 2015-03-12 | $3.2M | — | Filing → |
| EGRX | BUY | 2014-02-20 | $5.0M | — | Filing → |